In the present study, we established a trinitrobenzene sulfonic acid (TNBS)-induced chronic colonic fibrosis rat model characterized by CD pathology-like features and found that IDO-1 is necessary to achieve the effect of hADSCs-based treatment in an IBD model. The gene discussed is IDO1; the disease is inflammatory bowel disease.